Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma brucei | proteasome subunit beta type-2, putative | 0.0121 | 0.0987 | 0.1534 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.2604 | 0.4046 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.2604 | 0.4046 |
Echinococcus granulosus | proteasome prosome macropain subunit beta | 0.0121 | 0.0987 | 0.1534 |
Loa Loa (eye worm) | proteasome A-type and B-type family protein | 0.0265 | 0.6437 | 1 |
Plasmodium vivax | proteasome subunit beta type-2, putative | 0.0121 | 0.0987 | 0.1534 |
Echinococcus multilocularis | acetylcholinesterase | 0.0164 | 0.2604 | 0.4046 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0121 | 0.0987 | 0.1534 |
Toxoplasma gondii | proteasome subunit beta type, putative | 0.0265 | 0.6437 | 1 |
Loa Loa (eye worm) | proteasome subunit beta type 2 | 0.0121 | 0.0987 | 0.1534 |
Loa Loa (eye worm) | carboxylesterase | 0.0164 | 0.2604 | 0.4046 |
Echinococcus multilocularis | proteasome (prosome, macropain) | 0.0265 | 0.6437 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0265 | 0.6437 | 1 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0121 | 0.0987 | 0.1534 |
Brugia malayi | Proteasome A-type and B-type family protein | 0.0265 | 0.6437 | 1 |
Trypanosoma brucei | proteasome subunit beta type-5, putative | 0.0265 | 0.6437 | 1 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.0333 | 0.9042 | 1 |
Leishmania major | proteasome beta 2 subunit, putative | 0.0121 | 0.0987 | 0.1534 |
Entamoeba histolytica | proteasome subunit beta type 5 precursor, putative | 0.0265 | 0.6437 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-5, putative | 0.0265 | 0.6437 | 1 |
Plasmodium vivax | proteasome subunit beta type-5, putative | 0.0265 | 0.6437 | 1 |
Trypanosoma cruzi | proteasome subunit beta type-2, putative | 0.0121 | 0.0987 | 0.1534 |
Echinococcus granulosus | acetylcholinesterase | 0.0164 | 0.2604 | 0.4046 |
Schistosoma mansoni | proteasome catalytic subunit 3 (T01 family) | 0.0265 | 0.6437 | 1 |
Plasmodium falciparum | proteasome subunit beta type-5 | 0.0265 | 0.6437 | 1 |
Plasmodium falciparum | proteasome subunit beta type-2, putative | 0.0121 | 0.0987 | 0.1534 |
Toxoplasma gondii | proteasome subunit beta type 2, putative | 0.0121 | 0.0987 | 0.1534 |
Schistosoma mansoni | proteasome subunit beta 2 (T01 family) | 0.0121 | 0.0987 | 0.1534 |
Echinococcus granulosus | proteasome prosome macropain | 0.0265 | 0.6437 | 1 |
Echinococcus multilocularis | acetylcholinesterase | 0.0164 | 0.2604 | 0.4046 |
Trypanosoma cruzi | 20S proteasome subunit | 0.0121 | 0.0987 | 0.1534 |
Echinococcus granulosus | acetylcholinesterase | 0.0164 | 0.2604 | 0.4046 |
Schistosoma mansoni | family S9 non-peptidase homologue (S09 family) | 0.0164 | 0.2604 | 0.4046 |
Brugia malayi | proteasome subunit beta type 2 | 0.0121 | 0.0987 | 0.1534 |
Loa Loa (eye worm) | acetylcholinesterase 1 | 0.0164 | 0.2604 | 0.4046 |
Giardia lamblia | Proteasome subunit beta type 5 precursor | 0.0265 | 0.6437 | 1 |
Leishmania major | proteasome beta 5 subunit, putative | 0.0265 | 0.6437 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0164 | 0.2604 | 0.4046 |
Echinococcus multilocularis | carboxylesterase 5A | 0.0164 | 0.2604 | 0.4046 |
Schistosoma mansoni | proteasome subunit beta 2 (T01 family) | 0.0121 | 0.0987 | 0.1534 |
Brugia malayi | Carboxylesterase family protein | 0.0164 | 0.2604 | 0.4046 |
Mycobacterium leprae | proteasome (beta subunit) PrcB | 0.0265 | 0.6437 | 0.5 |
Entamoeba histolytica | probable proteasome subunit beta type 2, putative | 0.0121 | 0.0987 | 0.1534 |
Giardia lamblia | Proteasome subunit beta type 2 | 0.0121 | 0.0987 | 0.1534 |
Echinococcus granulosus | carboxylesterase 5A | 0.0164 | 0.2604 | 0.4046 |
Trichomonas vaginalis | Family T1, proteasome beta subunit, threonine peptidase | 0.0265 | 0.6437 | 1 |
Echinococcus multilocularis | proteasome (prosome, macropain) subunit, beta | 0.0121 | 0.0987 | 0.1534 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.